Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Renata FerrarottoIan AndersonBalazs MedgyasszayMaria Rosario García-CampeloWilliam EdenfieldTrevor M FeinsteinJennifer M JohnsonSujith KalmadiPhilip E LammersAlfredo Sanchez-HernandezYili PritchettShannon R MorrisRajesh K MalikTibor Csőszi

Published in: Cancer medicine (2021)

ClinicalTrials.gov (NCT02499770; NCT03041311; NCT02514447).

Keyphrases

chemotherapy induced
small cell lung cancer
phase iii
healthcare
double blind
palliative care
open label
placebo controlled
quality improvement
phase ii
locally advanced
clinical trial
brain metastases
pain management
radiation therapy
chronic pain